BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 38661582)

  • 1. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
    Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
    Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
    Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
    Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
    Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Intervention: Paclitaxel in Breast Cancer.
    Dan VM; Raveendran RS; Baby S
    Mini Rev Med Chem; 2021; 21(10):1237-1268. PubMed ID: 33319669
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.